Return to homepagePandemic Pact

Comparison of adaptive immunity between different Salmonella serovers

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R21AI196078-01

Grant search

Key facts

  • Disease

    Salmonella infection
  • Start & end year

    2026
    2028
  • Known Financial Commitments (USD)

    $412,206
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    STEPHEN MCSORLEY
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF CALIFORNIA AT DAVIS
  • Research Priority Alignment

    N/A
  • Research Category

    N/A

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project Summary/Abstract Systemic Salmonella infections have three main infectious causes (Typhi, Paratyphi, and a group of non- typhoidal serovars). Although new conjugate vaccines exist for Typhi, there are still no licensed vaccines for Paratyphi or non-typhoidal disease, despite the fact that they account for more than 50% of deaths due to systemic Salmonellosis. Since Typhi and Paratyphi serovars do not infect other animals, most of what we know about adaptive immunity to Salmonella comes from infection of mouse strains with NTS strains. In this application we will use a new mouse model that is permissive for Typhi infection and allows side-by-side analysis of typhoidal and non-typhoidal disease. We propose to, (i) validate this new model by testing whether typhoid strains have delayed T cell and B cell activation in vivo, and (ii) determine whether ViCPS expression allows evasion of adaptive immunity.